Publication | Closed Access

Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome

Hematological MalignancyTransplantationMarrow TransplantationDonor Lymphocyte InfusionsMyelodysplastic SyndromeStem Cell TransplantationHematologyCell TransplantationMedicineRadiation OncologyProphylactic Low-dose AzacitidineHealth Sciences